TCL Archive FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended July 28, 1989
TCL Archive ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer. March 24, 2006
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive Mysterious Group Urges Letters In Support Of Fisher, Calls For Investigation of NCI April 22, 1994
TCL Archive Cancer Genome Atlas Reveals Similarities Between Certain Breast and Ovarian Cancers September 28, 2012
